Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Digital Health & Informatics
Diversity, Equity and Inclusion
Health & Wellness
Opioids & Pain Management
Sterile Compounding
102 Views
Favorite
0
Like
Facebook
Tweet
Print
Email
Student Poster
(2-005) Evaluation of Adverse Event Reporting of Sotagliflozin to the U.S. Food and Drug Administration
Monday, December 9, 2024
10:45 AM – 11:45 AM
Location: Hall G, Lower Level
Category:
Evaluative Study
Topic:
Cardiology/Anticoagulation
Co-Author(s):
JingJing Qian
Primary Author(s)
Hallie E. Keiser